Aktivitet
-
Ypsomed launches YpsoLoop, the first autoinjector platform designed for circularity ♻️. The two new 1 ml and 2.25 ml platform versions enable…
Ypsomed launches YpsoLoop, the first autoinjector platform designed for circularity ♻️. The two new 1 ml and 2.25 ml platform versions enable…
Gillat av Lars Cederblad
-
Incredibly proud to announce that Ebrahim Anvari has successfully defended his PhD-thesis entitled ”The role of the innate immune system in the…
Incredibly proud to announce that Ebrahim Anvari has successfully defended his PhD-thesis entitled ”The role of the innate immune system in the…
Gillat av Lars Cederblad
-
GLP-1 and AID Systems — The Next Step in Hybrid Diabetes Therapy As automated insulin delivery (AID) systems mature, the next frontier is…
GLP-1 and AID Systems — The Next Step in Hybrid Diabetes Therapy As automated insulin delivery (AID) systems mature, the next frontier is…
Gillat av Lars Cederblad
Erfarenhet
Utbildning
Fler aktiviteter efter Lars
-
What’s in for AID systems in the next 3+ years? Automated insulin delivery (AID) is moving fast—from hybrid loops to systems that minimize or even…
What’s in for AID systems in the next 3+ years? Automated insulin delivery (AID) is moving fast—from hybrid loops to systems that minimize or even…
Gillat av Lars Cederblad
-
Early action in type 1 diabetes (T1D) can make an impact on diabetes care—where it's not just about treatment but about anticipation and preparation…
Early action in type 1 diabetes (T1D) can make an impact on diabetes care—where it's not just about treatment but about anticipation and preparation…
Gillat av Lars Cederblad
-
This week, we received feedback from one of our customers: "A consultant from Level21 Management AB deliver like 3 FTE's!" If you want to…
This week, we received feedback from one of our customers: "A consultant from Level21 Management AB deliver like 3 FTE's!" If you want to…
Gillat av Lars Cederblad
-
GlucoSet just received Breakthrough Device Designation from the FDA! We've been pursuing this for a year and a half. Landing it puts us on the…
GlucoSet just received Breakthrough Device Designation from the FDA! We've been pursuing this for a year and a half. Landing it puts us on the…
Gillat av Lars Cederblad
-
Deltog vid panelsamtal under rubriken "Shaping the Future of AI in Diabetes Care". Detta arrangerat av One Two Analytics och Beat Diabetes under…
Deltog vid panelsamtal under rubriken "Shaping the Future of AI in Diabetes Care". Detta arrangerat av One Two Analytics och Beat Diabetes under…
Gillat av Lars Cederblad
-
✨ The Future of AI in Diabetes Care – last night’s event was truly inspiring and sparked so many thoughts. This topic is especially close to my…
✨ The Future of AI in Diabetes Care – last night’s event was truly inspiring and sparked so many thoughts. This topic is especially close to my…
Gillat av Lars Cederblad
-
We are proud to announce that OneTwo Analytics in Sweden and GluCare.Health/metabolic in the UAE have signed a strategic agreement! GluCare.Health,…
We are proud to announce that OneTwo Analytics in Sweden and GluCare.Health/metabolic in the UAE have signed a strategic agreement! GluCare.Health,…
Gillat av Lars Cederblad
-
We are proud to announce that GluCare.Health/metabolic in the UAE and OneTwo Analytics in Sweden have signed a strategic agreement! GluCare.Health…
We are proud to announce that GluCare.Health/metabolic in the UAE and OneTwo Analytics in Sweden have signed a strategic agreement! GluCare.Health…
Gillat av Lars Cederblad
-
Tack för allt Beat Diabetes Foundation 💙 När jag 2017 satt i min sista intervju och Anders Jensen lade mitt CV åt sidan för att istället…
Tack för allt Beat Diabetes Foundation 💙 När jag 2017 satt i min sista intervju och Anders Jensen lade mitt CV åt sidan för att istället…
Gillat av Lars Cederblad
-
Incredible news from our portfolio company Piomic Medical! Craig CooperSerpentine VenturesSwiss Ventures GroupMike Baur
Incredible news from our portfolio company Piomic Medical! Craig CooperSerpentine VenturesSwiss Ventures GroupMike Baur
Gillat av Lars Cederblad
-
My Weekend on the Diabetes Rollercoaster Some people have asked me what a “diabetes rollercoaster” really feels like. It’s hard to explain to…
My Weekend on the Diabetes Rollercoaster Some people have asked me what a “diabetes rollercoaster” really feels like. It’s hard to explain to…
Gillat av Lars Cederblad
-
Excited to invite my network to this engaging seminar! Looking forward to connecting and seeing many of you there next week.
Excited to invite my network to this engaging seminar! Looking forward to connecting and seeing many of you there next week.
Delat av Lars Cederblad
-
That's a wrap #EASD2025! 🎉 The team at mylife thanks you for your participation, inspiring conversations, and the many valuable exchanges at our…
That's a wrap #EASD2025! 🎉 The team at mylife thanks you for your participation, inspiring conversations, and the many valuable exchanges at our…
Gillat av Lars Cederblad
-
🌍 Vienna, EASD 2025 – IDF AI Technology Committee Roundtable Following the success of our Mumbai roundtable, the International Diabetes Federation…
🌍 Vienna, EASD 2025 – IDF AI Technology Committee Roundtable Following the success of our Mumbai roundtable, the International Diabetes Federation…
Gillat av Lars Cederblad
-
🎤 Last weekend, wrapped up an engaging debate on "CGM Before Initiating Therapy in Every Drug-Naïve T2DM Patient" at DRS 2025, Mumbai - and the…
🎤 Last weekend, wrapped up an engaging debate on "CGM Before Initiating Therapy in Every Drug-Naïve T2DM Patient" at DRS 2025, Mumbai - and the…
Gillat av Lars Cederblad
-
The Blood Glucose Meter Story Is Repeating Itself – This Time with CGM Not too long ago, just before CGM came into the spotlight, the blood glucose…
The Blood Glucose Meter Story Is Repeating Itself – This Time with CGM Not too long ago, just before CGM came into the spotlight, the blood glucose…
Gillat av Lars Cederblad
Andra liknande profiler
Andra med namnet Lars Cederblad
1 person till med namnet Lars Cederblad är medlem på LinkedIn
Se andra med namnet Lars Cederblad